Krsnaa Diagnostics Limited
NSE:KRSNAA.NS
899.5 (INR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,863.4 | 1,702.32 | 1,332.26 | 1,583.22 | 1,554.49 | 1,395.79 | 1,332.26 | 1,180.98 | 1,229.4 | 1,128.59 | 1,082.47 | 1,064.68 | 1,082.63 | 1,324.72 | 959.12 | 688.08 |
| Cost of Revenue
| 622.7 | 1,097.86 | 416.86 | 527.62 | 561.78 | 451.55 | 256.91 | 191.89 | 173.32 | 119.67 | 127.03 | 117.46 | 135.88 | 222.59 | 359.84 | 105.2 |
| Gross Profit
| 1,240.7 | 604.46 | 915.4 | 1,055.6 | 992.71 | 944.24 | 1,075.35 | 989.09 | 1,056.08 | 1,008.92 | 955.44 | 947.22 | 946.75 | 1,102.13 | 599.28 | 582.88 |
| Gross Profit Ratio
| 0.666 | 0.355 | 0.687 | 0.667 | 0.639 | 0.676 | 0.807 | 0.838 | 0.859 | 0.894 | 0.883 | 0.89 | 0.874 | 0.832 | 0.625 | 0.847 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 123.41 | 94.19 | 184.01 | 202.62 | 173.86 | 159.95 | 164.46 | 212.75 | 274.9 | 248.29 | 274.39 | 274.13 | 283.11 | 211.82 | 207.27 |
| Selling & Marketing Expenses
| 0 | 269.03 | 322.97 | 201.14 | 207.82 | 229.18 | 31.91 | 175.66 | 141.25 | 161.03 | 18.09 | 142.59 | 128.17 | -3.24 | 1.77 | 2.21 |
| SG&A
| 396.15 | 392.44 | 417.16 | 385.15 | 410.44 | 403.04 | 359.47 | 340.12 | 354 | 435.93 | 497.31 | 416.98 | 402.3 | 279.87 | 358.14 | 269.07 |
| Other Expenses
| 0 | 73.16 | 43.38 | 40.78 | 41.58 | 42.22 | 59.26 | 45.43 | 42.7 | 46.4 | -108.05 | 43.39 | 32.3 | 32.38 | -3.36 | 0 |
| Operating Expenses
| 396.15 | 392.44 | 709.3 | 893.98 | 869.47 | 787.94 | 876.46 | 834.06 | 879.04 | 854.68 | 777.13 | 753.49 | 730.71 | 786.83 | 361.5 | 1,471.9 |
| Operating Income
| 271.99 | 212.02 | 206.1 | 202.4 | 164.82 | 156.3 | 258.15 | 200.46 | 219.74 | 154.24 | 178.3 | 193.73 | 216.04 | 347.68 | 237.78 | 91.57 |
| Operating Income Ratio
| 0.146 | 0.125 | 0.155 | 0.128 | 0.106 | 0.112 | 0.194 | 0.17 | 0.179 | 0.137 | 0.165 | 0.182 | 0.2 | 0.262 | 0.248 | 0.133 |
| Total Other Income Expenses Net
| -17.95 | 20 | -30.36 | -0.67 | 10.95 | 22.61 | -188.89 | 22.8 | 24.58 | 32.54 | 20.57 | 19.8 | -49.84 | -28.83 | -39.36 | -1,011.41 |
| Income Before Tax
| 254.04 | 232.02 | 235.79 | 160.95 | 134.19 | 178.91 | 235.79 | 177.83 | 201.62 | 186.78 | 198.9 | 213.53 | 166.2 | 286.47 | 198.42 | -919.84 |
| Income Before Tax Ratio
| 0.136 | 0.136 | 0.177 | 0.102 | 0.086 | 0.128 | 0.177 | 0.151 | 0.164 | 0.165 | 0.184 | 0.201 | 0.154 | 0.216 | 0.207 | -1.337 |
| Income Tax Expense
| 58.08 | 52.81 | 46.61 | 31.21 | 29.23 | 32.48 | 46.61 | 41.41 | 48.26 | 44.63 | 19.53 | 50.21 | 40.94 | 70.52 | 308.43 | 267.23 |
| Net Income
| 195.96 | 179.21 | 187.25 | 129.74 | 104.96 | 146.43 | 189.18 | 136.42 | 153.38 | 142.15 | 179.37 | 163.32 | 125.26 | 215.95 | -110.01 | -652.61 |
| Net Income Ratio
| 0.105 | 0.105 | 0.141 | 0.082 | 0.068 | 0.105 | 0.142 | 0.116 | 0.125 | 0.126 | 0.166 | 0.153 | 0.116 | 0.163 | -0.115 | -0.948 |
| EPS
| 6.07 | 5.55 | 6.02 | 4.09 | 3.35 | 4.66 | 6.02 | 4.35 | 5.73 | 4.51 | 5.44 | 5.67 | 4.51 | 6.88 | -8.47 | -63.2 |
| EPS Diluted
| 5.92 | 5.46 | 5.87 | 3.9 | 3.23 | 4.52 | 5.87 | 4.24 | 5.57 | 4.51 | 5.44 | 5.64 | 4.47 | 6.88 | -8.47 | -63.2 |
| EBITDA
| 539.94 | 499.84 | 480.4 | 414.71 | 359.46 | 355.87 | 404.11 | 339.51 | 348.93 | 324.26 | 321.3 | 343.46 | 351.66 | 447.44 | 330.72 | 175.02 |
| EBITDA Ratio
| 0.29 | 0.251 | 0.328 | 0.262 | 0.231 | 0.255 | 0.303 | 0.287 | 0.284 | 0.287 | 0.282 | 0.323 | 0.325 | 0.338 | 0.35 | 0.254 |